Verge Genomics is a clinical-stage biotechnology company transforming drug discovery and development using artificial intelligence (AI) and human data. Verge is focused on developing therapeutics for complex diseases with high unmet need, using human genomics from patient disease tissues and machine learning. Verge has created a proprietary all-in-human CONVERGE® platform, featuring one of the field’s largest and most comprehensive databases of multi-omic patient data.
The company is led by experienced computational biologists and drug developers who are successfully advancing clinical and preclinical therapeutic programs in various diseases, including ALS and Parkinson’s disease.
Verge actively seeks a diverse applicant pool in order to build the strongest possible workforce. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.
Company Details
- Employees
- 54
- Founded
- -
- Address
- 131 Oyster Point Blvd, South San Francisco,california 94080,united States
- he****@****ics.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- vergegenomics.com
- HQ
- South San Francisco, California
Verge Genomics Questions
Verge Genomics's website is vergegenomics.com
Verge Genomics's LinkedIn profile is https://www.linkedin.com/company/verge-genomics
Verge Genomics has
54 employees.
View email and phone details for 54
employees at Verge Genomics.
Verge Genomics's industry is
Biotechnology Research
Verge Genomics's top competitors are
Relay Therapeutics,
Recursion,
Benevolentai,
Insitro,
Exscientia,
Atomwise,
Insilico Medicine,
Freenome,
Deep Genomics,
Valo Health.
Verge Genomics's support email address is hello@vergegenomics.com
Verge Genomics's categories are Biotechnology Research
Verge Genomics's founding year is 2015
